# ClinicalTrials.gov record NCT06072963

> PeptideScanner retained ClinicalTrials.gov record NCT06072963 at 2026-08-10T18:10:03.864Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was semaglutide.

- Evidence object: `story:clinicaltrials-gov-nct06072963-semaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-27
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06072963-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06072963-semaglutide-v1.json
- Content SHA-256: `113d5f96c0ee587c86ceeb8dffb61e33ddcb9d1b0b66c5f8658b1ee681843bbe`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06072963 ([`ctg-observation-nct06072963-2026-07-27-483414b3f31d`](#source-ctg-observation-nct06072963-2026-07-27-483414b3f31d))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06072963 at 2026-08-10T18:10:03.864Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was semaglutide. ([`ctg-observation-nct06072963-2026-07-27-483414b3f31d`](#source-ctg-observation-nct06072963-2026-07-27-483414b3f31d))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06072963 at 2026-08-10T18:10:03.864Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was semaglutide. ([`ctg-observation-nct06072963-2026-07-27-483414b3f31d`](#source-ctg-observation-nct06072963-2026-07-27-483414b3f31d))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06072963-2026-07-27-483414b3f31d`](#source-ctg-observation-nct06072963-2026-07-27-483414b3f31d))

## Sources

<a id="source-ctg-observation-nct06072963-2026-07-27-483414b3f31d"></a>
- **ClinicalTrials.gov record NCT06072963 · retained source version 2026-07-27:483414b3f31df2407414d265560b7f9533166f51dda5a15edd5c9335023a83a1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06072963) (`ctg-observation-nct06072963-2026-07-27-483414b3f31d`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06072963." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06072963-semaglutide-v1.json SHA-256: 113d5f96c0ee587c86ceeb8dffb61e33ddcb9d1b0b66c5f8658b1ee681843bbe.